Intravenous immunoglobulin as an intervention strategy of risk factor modification for prevention of severe infection in heart transplantation.
作者信息
Sarmiento E, Arraya M, Jaramillo M, Diez P, Fernandez-Yañez J, Palomo J, Navarro J, Carbone J
机构信息
Transplant Immunology Group, Clinical Immunology Department, Hospital General Universitario Gregorio Marañon, Madrid, Spain.
出版信息
Clin Exp Immunol. 2014 Dec;178 Suppl 1(Suppl 1):156-8. doi: 10.1111/cei.12552.
Abstract
摘要
相似文献
1
Intravenous immunoglobulin as an intervention strategy of risk factor modification for prevention of severe infection in heart transplantation.静脉注射免疫球蛋白作为一种干预策略，用于通过改变危险因素预防心脏移植术后严重感染。
Clin Exp Immunol. 2014 Dec;178 Suppl 1(Suppl 1):156-8. doi: 10.1111/cei.12552.
2
Hypogammaglobulinemia and infection risk in solid organ transplant recipients.实体器官移植受者的低丙种球蛋白血症与感染风险
Curr Opin Organ Transplant. 2008 Dec;13(6):581-5. doi: 10.1097/MOT.0b013e3283186bbc.
3
Advances of intravenous immunoglobulin G in modulation of anti-fetal immunity in selected at-risk populations: science and therapeutics.静脉注射免疫球蛋白G在特定高危人群中调节抗胎儿免疫方面的进展：科学与治疗
Clin Exp Immunol. 2014 Dec;178 Suppl 1(Suppl 1):120-2. doi: 10.1111/cei.12536.
4
Early intravenous immunoglobulin replacement in hypogammaglobulinemic heart transplant recipients: results of a clinical trial.低丙种球蛋白血症心脏移植受者早期静脉注射免疫球蛋白替代治疗：一项临床试验的结果
Transpl Infect Dis. 2016 Dec;18(6):832-843. doi: 10.1111/tid.12610. Epub 2016 Oct 25.
5
Dose and outcomes in primary immunodeficiency disorders.原发性免疫缺陷病的剂量与结局
Clin Exp Immunol. 2014 Dec;178 Suppl 1(Suppl 1):7-9. doi: 10.1111/cei.12492.
6
Intravenous immunoglobulin G in the treatment of autoimmune bullous disease.静脉注射免疫球蛋白G治疗自身免疫性大疱性疾病。
Clin Exp Immunol. 2014 Dec;178 Suppl 1(Suppl 1):118-9. doi: 10.1111/cei.12535.
7
The potential impact of substitutive therapy with intravenous immunoglobulin on the outcome of heart transplant recipients with infections.静脉注射免疫球蛋白替代疗法对心脏移植受者感染结局的潜在影响。
Transplant Proc. 2007 Sep;39(7):2385-8. doi: 10.1016/j.transproceed.2007.06.050.
8
Restoration of humoral immunity after intravenous immunoglobulin replacement therapy in heart recipients with post-transplant antibody deficiency and severe infections.心脏移植后抗体缺乏伴严重感染患者静脉注射免疫球蛋白替代治疗后体液免疫的恢复。
Clin Transplant. 2012 May-Jun;26(3):E277-83. doi: 10.1111/j.1399-0012.2012.01653.x.
9
Biologic IgG level in primary immunodeficiency disease: the IgG level that protects against recurrent infection.原发性免疫缺陷病中的生物性IgG水平：预防反复感染的IgG水平。
J Allergy Clin Immunol. 2008 Jul;122(1):210-2. doi: 10.1016/j.jaci.2008.04.044.
10
Hypogammaglobulinaemia.低丙种球蛋白血症
Immunol Allergy Clin North Am. 2008 Nov;28(4):691-713, vii. doi: 10.1016/j.iac.2008.06.003.
引用本文的文献
1
Current and emerging tools for simultaneous assessment of infection and rejection risk in transplantation.用于同时评估移植中感染和排斥风险的现有及新兴工具。
Front Immunol. 2024 Nov 26;15:1490472. doi: 10.3389/fimmu.2024.1490472. eCollection 2024.
本文引用的文献
1
Evaluation of humoral immunity profiles to identify heart recipients at risk for development of severe infections: A multicenter prospective study.评价体液免疫谱以识别心脏受者发生严重感染的风险：一项多中心前瞻性研究。
J Heart Lung Transplant. 2017 May;36(5):529-539. doi: 10.1016/j.healun.2016.10.004. Epub 2016 Oct 17.
2
Polyclonal intravenous immunoglobulin: an important additional strategy in sepsis?多克隆静脉注射免疫球蛋白：脓毒症治疗中的一项重要辅助策略？
Eur J Intern Med. 2014 Jul;25(6):511-6. doi: 10.1016/j.ejim.2014.05.002. Epub 2014 May 27.
3
What is the impact of hypogammaglobulinemia on the rate of infections and survival in solid organ transplantation? A meta-analysis.低丙种球蛋白血症对实体器官移植感染率和生存率的影响：一项荟萃分析。
Am J Transplant. 2013 Oct;13(10):2601-10. doi: 10.1111/ajt.12401. Epub 2013 Aug 6.
4
Decreased levels of serum complement C3 and natural killer cells add to the predictive value of total immunoglobulin G for severe infection in heart transplant recipients.血清补体C3水平降低和自然杀伤细胞减少增加了心脏移植受者中总免疫球蛋白G对严重感染的预测价值。
Transpl Infect Dis. 2012 Oct;14(5):526-39. doi: 10.1111/j.1399-3062.2012.00757.x.
5
Restoration of humoral immunity after intravenous immunoglobulin replacement therapy in heart recipients with post-transplant antibody deficiency and severe infections.心脏移植后抗体缺乏伴严重感染患者静脉注射免疫球蛋白替代治疗后体液免疫的恢复。
Clin Transplant. 2012 May-Jun;26(3):E277-83. doi: 10.1111/j.1399-0012.2012.01653.x.
6
Management of immune dysfunction after adult cardiac surgery.成人心脏手术后免疫功能障碍的管理。
J Thorac Cardiovasc Surg. 2011 Sep;142(3):575-80. doi: 10.1016/j.jtcvs.2011.04.042. Epub 2011 Jul 2.
7
Immunological risk factors for infection after immunosuppressive and biologic therapies.免疫抑制和生物治疗后感染的免疫风险因素。
Expert Rev Anti Infect Ther. 2011 Apr;9(4):405-13. doi: 10.1586/eri.10.178.
8
IgG monitoring to identify the risk for development of infection in heart transplant recipients.监测心脏移植受者的IgG水平以确定感染发生风险。
Transpl Infect Dis. 2006 Mar;8(1):49-53. doi: 10.1111/j.1399-3062.2006.00136.x.
9
The impact of CytoGam on cardiac transplant recipients with moderate hypogammaglobulinemia: a randomized single-center study.细胞球蛋白（CytoGam）对中度低丙种球蛋白血症心脏移植受者的影响：一项单中心随机研究。
J Heart Lung Transplant. 2005 Nov;24(11):1766-9. doi: 10.1016/j.healun.2004.11.016.
10
Hypogammaglobulinemia after heart transplantation: impact of pre-emptive use of immunoglobulin replacement (CytoGam) on infection and rejection outcomes.
Transpl Infect Dis. 2001;3 Suppl 2:40-3. doi: 10.1034/j.1399-3062.2001.00008.x.
Zotero 插件